• Thumbnail for Vesicular monoamine transporter 2
    18 member 2 (SLC18A2) also known as vesicular monoamine transporter 2 (VMAT2) is a protein that in humans is encoded by the SLC18A2 gene. SLC18A2 is...
    20 KB (2,213 words) - 03:49, 12 August 2024
  • Thumbnail for Valbenazine
    treat tardive dyskinesia. It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor. Valbenazine is used to treat tardive dyskinesia in adults. Tardive...
    12 KB (879 words) - 03:18, 26 September 2024
  • heredity and that a specific gene, called vesicular monoamine transporter 2 (VMAT2), predisposes humans towards spiritual or mystic experiences. The idea has...
    9 KB (1,046 words) - 11:06, 4 April 2024
  • rat adrenal medulla cells, whereas VMAT2 is the major transporter in bovine adrenal medulla cells. VMAT1 and VMAT2 are acidic glycoproteins with a molecular...
    43 KB (4,991 words) - 02:50, 30 August 2024
  • Thumbnail for Adderall
    amine-associated receptor 1 (hTAAR1) and vesicular monoamine transporter 2 (VMAT2) in neurons. Dextroamphetamine is a more potent Central nervous system (CNS)...
    58 KB (21,548 words) - 19:20, 8 October 2024
  • Thumbnail for Amphetamine
    for the presynaptic vesicular monoamine transporter, VMAT2. Following amphetamine uptake at VMAT2, amphetamine induces the collapse of the vesicular pH...
    274 KB (28,854 words) - 09:38, 23 October 2024
  • Thumbnail for Phentermine
    synapses as well. Phentermine may also trigger the release of monoamines from VMAT2, which is a common pharmacodynamic effect among substituted amphetamines...
    20 KB (1,727 words) - 05:16, 1 November 2024
  • Thumbnail for Reserpine
    VMAT1 and VMAT2. VMAT1 is mostly expressed in neuroendocrine cells. VMAT2 is mostly expressed in neurons. Thus, it is the blockade of neuronal VMAT2 by reserpine...
    28 KB (2,899 words) - 15:25, 21 October 2024
  • Thumbnail for Norepinephrine–dopamine reuptake inhibitor
    Amphetamine and many of the other substituted amphetamines are inhibitors of VMAT2 and potent agonists of the trace amine-associated receptor 1 (TAAR1); agonism...
    6 KB (418 words) - 04:31, 25 July 2024
  • Thumbnail for Tetrabenazine
    of vesicular monoamine transporter 2 (VMAT2) also known as solute carrier family 18 member 2 (SLC18A2). VMAT2 is a protein which depletes dopamine (DA)...
    21 KB (1,866 words) - 07:17, 19 October 2024
  • Thumbnail for Neurotransmitter
    TAAR1, a presynaptic G protein-coupled receptor, and binding to a site on VMAT2, a type of monoamine transporter located on synaptic vesicles within monoamine...
    94 KB (8,335 words) - 00:41, 23 October 2024
  • Thumbnail for Dopaminergic
    such as the dopamine transporter (DAT), vesicular monoamine transporter 2 (VMAT2), and dopamine receptors can be classified as dopaminergic, and neurons...
    28 KB (2,798 words) - 23:11, 22 October 2024
  • Thumbnail for Methamphetamine
    transporters, methamphetamine inhibits synaptic vesicle function by inhibiting VMAT2, which prevents monoamine uptake into the vesicles and promotes their release...
    156 KB (15,398 words) - 12:48, 28 October 2024
  • Thumbnail for Phenethylamine
    amine-associated receptor 1 (TAAR1) and inhibiting vesicular monoamine transporter 2 (VMAT2) in monoamine neurons. To a lesser extent, it also acts as a neurotransmitter...
    46 KB (4,510 words) - 12:55, 16 October 2024
  • Thumbnail for Substantia nigra
    monoamine transporter, vesicular monoamine transporter 2 (VMAT2). When amphetamine is taken up by VMAT2, the vesicle releases (effluxes) dopamine molecules...
    47 KB (5,481 words) - 14:33, 13 October 2024
  • Thumbnail for Bupropion
    dose) in a PET study. Bupropion has also been shown to increase striatal VMAT2, though it is unknown if this effect is more pronounced than other DRIs...
    137 KB (12,534 words) - 10:50, 22 October 2024
  • Thumbnail for Lisdexamfetamine
    07109.x. PMC 3005101. PMID 21073468. Eiden LE, Weihe E (January 2011). "VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting...
    45 KB (14,062 words) - 20:53, 26 October 2024
  • Thumbnail for Psychedelic drug
    CNS and inhibiting vesicular monoamine transporter 2 (VMAT2) in monoamine neurons. When VMAT2 is inhibited monoamine neurotransmitters such as dopamine...
    87 KB (9,054 words) - 05:43, 8 October 2024
  • Thumbnail for MDMA
    potential-evoked neurotransmitter release. Inside the neuron, MDMA inhibits VMAT2 and activates TAAR1. TAAR1 agonism results in the phosphorylation of monoamine...
    166 KB (15,980 words) - 10:15, 1 November 2024
  • transport at vesicular monoamine transporters (specifically, VMAT1 and VMAT2) and other monoamine transporters that are located along the plasma membrane...
    7 KB (584 words) - 01:21, 7 December 2020
  • Thumbnail for Bipolar disorder
    bipolar disorder as well as symptoms of mania, implicating dopamine in mania. VMAT2 binding was found to be increased in one study of people with bipolar mania...
    157 KB (17,739 words) - 17:48, 28 October 2024
  • Thumbnail for Dopamine
    synaptic vesicles by a solute carrier—a vesicular monoamine transporter, VMAT2. Dopamine is stored in these vesicles until it is ejected into the synaptic...
    139 KB (14,249 words) - 04:40, 28 September 2024
  • a mutation in SLC18A2, which encodes vesicular monoamine transporter 2 (VMAT2). "dysdiadochokinesia". Merriam-Webster.com Dictionary. Merriam-Webster...
    6 KB (533 words) - 11:23, 12 July 2024
  • Thumbnail for Dihydrotetrabenazine
    are used as PET radioligands for examining VMAT2. [11C]DTBZ as a PET radioligand with affinity for VMAT2 was developed in the mid 1990s by David E. Kuhl...
    6 KB (500 words) - 03:22, 26 September 2024
  • Thumbnail for Monoamine neurotransmitter
    outer cell membrane and the vesicular monoamine transporter (VMAT1 and VMAT2) in the membrane of intracellular vesicles.[citation needed] After release...
    7 KB (1,409 words) - 21:17, 11 March 2024
  • Thumbnail for Monoamine-depleting agent
    inhibiting reuptake by the vesicular monoamine transporters, VMAT1 and VMAT2. Examples of monoamine-depleting agents include deutetrabenazine, oxypertine...
    3 KB (252 words) - 01:20, 3 September 2024
  • Thumbnail for Solute carrier family 10 member 4
    containing monoamines, enhancing their uptake, and is co-expressed with VMAT2 and VAChT. GRCh38: Ensembl release 89: ENSG00000145248 – Ensembl, May 2017...
    2 KB (209 words) - 14:24, 7 September 2023
  • Thumbnail for Trace amine
    as both compounds induce efflux from vesicular monoamine transporter 2 (VMAT2) and activate TAAR1 with comparable efficacy. Like dopamine, norepinephrine...
    20 KB (2,302 words) - 05:17, 18 August 2024
  • Thumbnail for Antiporter
    electrochemical gradient created by a vesicular hydrogen proton-ATPase. VMAT1 and VMAT2 are two isoforms that can transport monoamines such as serotonin, norepinephrine...
    61 KB (7,825 words) - 09:17, 6 October 2024
  • Thumbnail for Nucleus accumbens
    the reuptake and release of dopamine into the Nacc via interactions with VMAT2 and TAAR1 in the axon terminal of mesolimbic dopamine neurons. Glucocorticoids...
    80 KB (9,795 words) - 00:52, 20 October 2024